Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityNo recent work listed

Hongli Xu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-6201-3873; OpenAlex author ID A5083793874. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2014: 1 paper · 2015: 1 paper

Papers 2

  1. Urinary prostaglandin E2 metabolite and pancreatic cancer risk: case-control study in urban Shanghai. Co-author DOI 10.1371/journal.pone.0118004↗
  2. Re-evaluation of ABO gene polymorphisms detected in a genome-wide association study and risk of pancreatic ductal adenocarcinoma in a Chinese population. Co-author DOI 10.5732/cjc.013.10060↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Herbert Yu · 2 shared papers, 2014–2015 · strength 0.09
  2. Harvey A. Risch Risch · 2 shared papers, 2014–2015 · strength 0.09
  3. Quanxing Ni · 1 shared paper, 2015 · strength 0.05
  4. Jing Zhao · 1 shared paper, 2015 · strength 0.05
  5. Yu‐Tang Gao · 1 shared paper, 2015 · strength 0.05
  6. Ying Gao · 1 shared paper, 2015 · strength 0.05
  7. Yu-Tang Gao · 1 shared paper, 2014 · strength 0.04
  8. Jing Wang · 1 shared paper, 2014 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.